1210
K. Fujita et al. / Tetrahedron 72 (2016) 1205e1212
121.8, 107.7, 102.3, 71.7, 70.5, 70.3, 70.2, 69.4, 67.6, 58.8, 53.3; Anal.
Calcd for C61H105BrN2O24: C, 55.07; H, 7.96; N, 2.11; Br, 6.01%.
Found: C, 55.06; H, 8.07; N, 1.99; Br, 5.94%.
Anal. Calcd for C117H120AuClN2O28: C, 62.89; H, 5.41; N, 1.25; Cl,
1.59%. Found: C, 62.87; H, 5.40; N, 1.08; Cl, 1.47%.
4.3.4. Chloro{1,3-bis(3,5-bis[2-{2-(2-methoxyethoxy)ethoxy}ethoxy]
benzyl)imidazol-2-ylidene}gold(I) (1G1[TEG]). Pale yellow oil; IR
(Neat) 3102, 2876, 1735, 1598, 1451, 1351, 1298, 1244, 1125,
4.2.8. 1,3-Bis{3,5-bis(2,5,8,11,14,17,20,23,26,29,32,35-
dodecaoxaheptatriacontan-37-yloxy)benzyl}imidazolium bromide (3G1
[DEG]). Colorless oil; IR (Neat) 2872, 1598, 1447, 1349, 1300, 1250,
850 cmꢁ1 1H NMR (400 MHz; CD3OD)
; d 7.31 (s, 2H, Im), 6.56 (d,
1134, 951, 851, 764 cmꢁ1
;
1H NMR (400 MHz; CDCl3)
d
10.89 (s, 1H,
J¼2.1 Hz, 4H, ArH), 6.44 (t, J¼2.1 Hz, 2H, ArH), 5.24 (s, 4H, NCH2Ar),
4.06 (t, J¼4.6 Hz, 8H, OCH2CH2), 3.78 (t, J¼4.6 Hz, 8H, CH2CH2O),
3.68e3.57 (m, 24H, OCH2CH2O), 3.52e3.48 (m, 8H, CH2CH2O), 3.32
Im), 7.36 (s, 2H, Im), 6.73 (s, 4H, ArH), 6.49 (s, 2H, ArH), 5.44 (s, 4H,
NCH2Ar), 4.15 (t, J¼4.4 Hz, 8H, OCH2CH2), 3.84 (t, J¼4.6 Hz, 8H,
CH2CH2O), 3.77e3.44 (m, 176H, OCH2CH2O), 3.38 (s, 12H, OCH3); 13C
(s, 12H, OCH3); 13C NMR (100 MHz; CD3OD)
d 171.6, 161.7, 139.9,
NMR (100 MHz; CDCl3)
70.5, 70.3, 69.5, 67.7, 58.9, 53.3; Anal. Calcd for
117H217BrN2O52$5.5H2O: C, 52.77; H, 8.63; N, 1.05%. Found: C, 52.39;
d
160.4, 137.2, 134.9, 121.9, 107.7, 102.5, 71.8,
123.0, 107.8, 102.7, 73.0, 71.7, 71.6, 71.4, 70.7, 68.8, 59.1, 55.8; Anal.
Calcd for C45H72AuClN2O16: C, 47.85; H, 6.43; N, 2.48; Cl, 3.14%.
Found: C, 47.65; H, 6.43; N, 2.31; Cl, 2.81%.
C
H, 8.38; N, 0.83%.
4.3.5. Chloro[1,3-bis{3,5-bis(3,5-bis[2-{2-(2-methoxyethoxy)ethoxy}
ethoxy]benzyloxy)benzyl}imidazol-2-ylidene]gold(I) (1G2[TEG]). Pale
yellow oil; IR (Neat) 2873, 1594, 1447, 1351, 1298, 1174, 1069,
846 cmꢁ1; 1H NMR (400 MHz; CD3OD)
d 7.17 (s, 2H, Im), 6.55e6.48
4.3. Synthesis of a dendritic NHCeGold(I) complex 1Gn[X]
from 3Gn[X] (Table 1 and Scheme 3): typical procedure
(m,14H, ArH), 6.41 (t, J¼2.1 Hz, 4H, ArH), 5.18 (s, 4H, NCH2Ar), 4.88 (s,
8H, OCH2Ar), 4.04 (t, J¼4.6 Hz, 16H, OCH2CH2), 3.76 (t, J¼4.6 Hz, 16H,
CH2CH2O), 3.66e3.62 (m, 16H, OCH2CH2), 3.61e3.55 (m, 32H,
A suspension of a dendritic imidazolium bromide 3G1[Me]
(300.2 mg, 0.668 mmol) and silver(I) oxide (77.8 mg, 0.336 mmol)
in dry 1,2-dichloroethane (25 mL) was stirred at 70 ꢀC for 3 h under
an argon atmosphere. The completion of the reaction was detected
by 1H NMR. After the reaction mixture was cooled to room tem-
perature, AuCl(SMe2) (196.3 mg, 0.666 mmol) was added. The
resulting mixture was stirred at room temperature for 3 h under an
argon atmosphere. The mixture was then concentrated to dryness,
and the residue was filtered through CeliteÒ to remove insoluble
materials. After evaporation of the filtrate, the residue was purified
with silica gel column chromatography (hexane/ethyl acetate¼1/1
as eluent) to obtain a dendritic NHCegold(I) complex 1G1[Me]
(314.3 mg, 0.523 mmol) in a 78% yield.
OCH2CH2O), 3.50e3.46 (m, 16H, CH2CH2O), 3.30 (s, 24H, OCH3); 13
C
NMR (100 MHz; CD3OD) d 171.6, 161.5, 161.4, 140.9, 140.0, 123.1, 108.2,
107.2, 103.4, 102.1, 73.0, 71.7, 71.6, 71.4, 71.0, 70.8, 68.8, 59.2, 55.7;
Anal. Calcd for C101H152AuClN2O36$2H2O: C, 54.19; H, 7.02; N,1.25; Cl,
1.58%. Found: C, 53.86; H, 6.91; N, 1.10; Cl, 1.47%.
4.3.6. Chloro(1,3-bis[3,5-bis{3,5-bis(3,5-bis[2-{2-(2-methoxyethoxy)
ethoxy}ethoxy]benzyloxy) benzyloxy}benzyl]imidazol-2-ylidene)gold(I)
(1G3[TEG]). Pale yellow oil; IR (Neat) 2876, 1594, 1447, 1350, 1298,
1174, 1069, 845 cmꢁ1; 1H NMR (400 MHz; CDCl3)
d 6.89 (s, 2H, Im),
6.66 (d, J¼2.0 Hz, 8H, ArH), 6.58 (d, J¼2.0 Hz, 16H, ArH), 6.56 (t,
J¼2.0 Hz, 2H, ArH), 6.54 (t, J¼2.2 Hz, 4H, ArH), 6.53 (t, J¼2.2 Hz, 4H,
ArH), 6.44 (t, J¼2.2 Hz, 8H, ArH), 5.26 (s, 4H, NCH2Ar), 4.95 (s, 24H,
OCH2Ar), 4.09 (t, J¼4.8 Hz, 32H, OCH2CH2), 3.82 (t, J¼4.8 Hz, 32H,
CH2CH2O), 3.74e3.69 (m, 32H, OCH2CH2), 3.68e3.61 (m, 64H,
4.3.1. Chloro{1,3-bis(3,5-dimethoxybenzyl)imidazol-2-ylidene}
gold(I) (1G1[Me]). White powder; mp 174e176 ꢀC; IR (KBr) 2944,
OCH2CH2O), 3.55e3.51 (m, 32H, CH2CH2O), 3.36 (s, 48H, OCH3); 13
C
2839, 1600, 1454, 1419, 1357, 1300, 1208, 1164, 1070, 785, 697 cmꢁ1
;
1H NMR (400 MHz; CDCl3)
ArH), 5.29 (s, 4H, NCH2Ar), 3.78 (s, 12H, OCH3); 13C NMR (100 MHz;
CDCl3) 171.5, 161.3, 137.1, 120.9, 106.1, 100.4, 55.5, 55.2; Anal. Calcd
d
6.88 (s, 2H, Im), 6.50e6.39 (m, 6H,
NMR (100 MHz; CDCl3)
d 171.1, 160.3, 160.1, 139.0, 138.9, 137.4, 121.1,
107.1, 106.5, 106.1, 101.9, 101.6, 101.1, 71.9, 70.8, 70.6, 70.5, 70.1, 70.0,
69.6, 67.5, 59.0, 55.1; Anal. Calcd for C213H312AuClN2O76: C, 58.82; H,
7.23; N, 0.64; Cl, 0.82%. Found: C, 59.09; H, 7.32; N, 0.54; Cl, 0.80%.
d
for C21H24AuClN2O4$0.3H2O: C, 41.60; H, 4.09; N, 4.62; Cl, 5.85%.
Found: C, 41.54; H, 3.88; N, 4.33; Cl, 6.23%.
4.3.7. Chloro[1,3-bis{3,5-bis(2,5,8,11,14-pentaoxahexadecane-16-
yloxy)benzyl}imidazol-2-ylidene]gold(I) (1G1[PEG]). Pale yellow oil;
IR (Neat) 2872,1594,1447, 1349,1298,1246,1119, 949, 851 cmꢁ1; 1H
4.3.2. Chloro[1,3-bis{3,5-bis(3,5-dimethoxybenzyloxy)benzyl}imida-
zol-2-ylidene]gold(I) (1G2[Me]). White powder; mp 132e134 ꢀC; IR
(KBr) 2998, 2938, 2838, 1599, 1459, 1430, 1349, 1154, 1056,
NMR (400 MHz; CDCl3)
d
6.87 (s, 2H, Im), 6.49 (d, J¼2.1 Hz, 4H,
834 cmꢁ1; 1H NMR (400 MHz; CDCl3)
d 6.79 (s, 2H, Im), 6.57e6.50
ArH), 6.45 (t, J¼2.1 Hz, 2H, ArH), 5.26 (s, 4H, NCH2Ar), 4.09 (t,
J¼4.7 Hz, 8H, OCH2CH2), 3.83 (t, J¼4.7 Hz, 8H, CH2CH2O), 3.73e3.62
(m, 56H, OCH2CH2O), 3.56e3.52 (m, 8H, CH2CH2O), 3.37 (s, 12H,
(m, 14H, ArH), 6.40 (t J¼2.0 Hz, 4H, ArH), 5.26 (s, 4H, NCH2Ar), 4.95
(s, 8H, OCH2Ar), 3.79 (s, 24H, OCH3); 13C NMR (100 MHz; CDCl3)
OCH3); 13C NMR (100 MHz; CDCl3)
d 171.2, 160.4, 136.9, 120.9, 107.1,
d
171.5,161.0,160.3,138.9,137.1,120.9,107.2,105.2,102.2,100.0, 70.1,
101.5, 71.9, 70.7, 70.6, 70.54, 70.53, 70.47, 69.5, 67.6, 59.0, 55.2; Anal.
Calcd for C61H104AuClN2O24: C, 49.44; H, 7.07; N, 1.89; Cl, 2.39%.
Found: C, 49.54; H, 7.09; N, 1.77; Cl, 2.21%.
55.4, 55.1; Anal. Calcd for C53H56AuClN2O12: C, 55.57; H, 4.93; N,
2.45; Cl, 3.10%. Found: C, 55.43; H, 4.86; N, 2.23; Cl, 3.07%.
4.3.3. Chloro(1,3-bis[3,5-bis{3,5-bis(3,5-dimethoxybenzyloxy)ben-
zyloxy}benzyl]imidazol-2-ylidene)gold(I) (1G3[Me]). White powder;
mp 67e69 ꢀC; IR (KBr) 2998, 2937, 2838, 1594, 1456, 1374, 1324,
4.3.8. Chloro[1,3-bis{3,5-bis(2,5,8,11,14,17,20,23,26,29,32,35-
dodecaoxaheptatriacontan-37-yloxy)benzyl}imidazol-2-ylidene]
gold(I) (1G1[DEG]). Pale yellow oil; IR (Neat) 2873, 1597, 1451, 1349,
1205, 1157, 1053, 833 cmꢁ1; 1H NMR (400 MHz; CDCl3)
d 6.75 (s, 2H,
1298, 1248, 1118, 950, 851 cmꢁ1; 1H NMR (400 MHz; CDCl3)
d 6.89
Im), 6.63 (d, J¼2.0 Hz, 8H, ArH), 6.56 (d, J¼2.4 Hz, 16H, ArH), 6.54 (t,
J¼2.2 Hz, 4H, ArH), 6.51 (t, J¼2.0 Hz, 2H, ArH), 6.45 (t, J¼2.0 Hz, 4H,
ArH), 6.39 (t, J¼2.2 Hz, 8H, ArH), 5.20 (s, 4H, NCH2Ar), 4.96 (s, 16H,
OCH2Ar), 4.92 (s, 8H, OCH2Ar), 3.76 (s, 48H, OCH3); 13C NMR
(s, 2H, Im), 6.49 (d, J¼2.0 Hz, 4H, ArH), 6.45 (d, J¼2.0 Hz, 2H, ArH),
5.26 (s, 4H, NCH2Ar), 4.09 (t, J¼4.4 Hz, 8H, OCH2CH2), 3.83 (t,
J¼4.6 Hz, 8H, CH2CH2O), 3.77e3.44 (m, 176H, OCH2CH2O), 3.38 (s,
12H, OCH3); 13C NMR (100 MHz; CDCl3)
d 171.0, 160.3, 136.9, 120.9,
(100 MHz; CDCl3)
d 171.4, 160.9, 160.2, 160.0, 139.1, 139.0, 137.3,
107.0, 101.4, 71.9, 70.9, 70.7, 70.5, 69.5, 67.5, 59.0, 55.2; Anal. Calcd
120.9, 107.0, 106.3, 105.2, 102.1, 101.7, 99.9, 70.0, 55.7, 55.3, 55.0;